Litigation Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2020)
✉ Email this page to a colleague
JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-09-23 |
Court | District Court, D. New Jersey | Date Terminated | 2023-05-23 |
Cause | 15:1126 Patent Infringement | Assigned To | Evelyn Padin |
Jury Demand | None | Referred To | Leda Dunn Wettre |
Patents | 10,143,693; 9,439,906 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED
Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-03-21 | 148 | Redacted Document | Patent-In-Suit 693 Patent U.S. Patent No. 10,143,693 Asserted Claims…obviousness-type double patenting over claims 1-16 of US Patent No. 9,439,906 (the 906 Patent) in view of Osborne… for obviousness-type double patenting over the 906 Patent (the patent that issued from the 519 Publication… and an earlier patent incorporated by reference in the 693 Patent, the 693 Patent disclosure would…24 (Berger). IV. THE 693 PATENT 19. The 693 Patent “relates to a method for treating | External link to document |
2023-03-21 | 149 | Redacted Document | of the patent-in-suit. That is why U.S. Patent No. 10,143,693 (“the ’693 patent”) thwarts … such patents. Examining the actual prosecution history of the patent reveals what the patent truly…JAMA to the patent office when prosecuting the ’693 patent. Without JAMA before the patent examiner, …this patent in the first place. Because when Janssen’s patent was rejected by the patent office…obtained the ’693 patent by telling the patent office that it was nothing like the ’906 patent because the | External link to document |
2023-03-21 | 150 | Redacted Document | Patent-In-Suit 693 Patent U.S. Patent No. 10,143,693 Asserted Claims…including Dr. Forrest’s own patents—the structural features in the 693 Patent are entirely adequate to…It is a bedrock principle of patent law that the claims of a patent define the invention to which the…there are “two elements of a simple patent case, construing the patent and determining whether infringement…) 519 Publication PTX-115 United States Patent Application Publication DTX | External link to document |
2023-05-15 | 172 | Order | Products”), infringe upon JPN’s U.S. Patent No. 10,143,693 (the “693 Patent”), specifically Claims 5-7 and…Products will induce direct infringement of the 693 Patent. Mylan has failed to demonstrate that the Asserted…Products will induce direct infringement of the 693 Patent; and it is further Case 2:20-cv-13103-EP-LDW Document… 2020 23 May 2023 2:20-cv-13103 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |